# AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine

> **NCT05324852** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1 (actual)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Intranasal midazolam
- **DRUG:** Intramuscular loxapine

## Key facts

- **NCT ID:** NCT05324852
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-09
- **Primary completion:** 2023-04-09
- **Final completion:** 2024-04-23
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor decision:
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324852, "AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05324852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*